First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)

NCT04638790 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma, Adult

Interventions

DRUG: Doxorubicin
DRUG: Bleomycin
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Dacarbazine

Sponsor

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia